A real-world disproportionality analysis of apalutamide: data mining of the FDA adverse event reporting system.

Front Pharmacol · 2023 · PMC10277739 · PMID 37342589

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Apalutamide is a well-tolerated drug for PCa patients and is associated with a favorable trend of improved overall survival.

also in 1,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.